Rebecca Allen-Tapp

In 2019, Rebecca faced a life-changing diagnosis of neuroendocrine cancer, which resulted in the sudden removal of her left lung. But instead of letting the diagnosis define her, she chose to channel her energy into achieving new heights. With her experience in the cannabis industry, she explored the benefits of cannabis use for therapeutic purposes and found relief from her symptoms.Rebecca’s work as Director of Business Development for a leading laboratory equipment distributor was marked by her unwavering dedication to driving innovation and spearheading transformative initiatives. Her unmatched commitment to customer service and business strategy propelled the company to expand its reach and influence in emerging markets, with a specific focus on cannabis and psilocybin.Her experience inspired her to deepen her understanding of the science and production process behind cannabis products and medicines, leading her to relocate from the US to the UK to join the Syrris AGI UK team as Business Development Manager. In this role, she is developing an application-specific channel with an award-winning chemical reactor company to optimize systems for cannabis.Rebecca’s public speaking abilities have earned her a reputation as a thought leader in the industry. Her relentless drive and passion for excellence are evident in the way she inspires and educates audiences worldwide about the potential benefits of cannabis for therapeutic purposes.Rebecca’s journey serves as a source of inspiration to others, and she continues to use her voice and platform to advocate for education and drug policy reform. As the global conversation around cannabis evolves, Rebecca remains at the forefront of the movement, leading the charge for change and making a meaningful impact in the lives of countless individuals. Her achievements are a testament to her incredible spirit and unwavering determination.